1.44Open1.25Pre Close116 Volume22 Open Interest30.50Strike Price16.56KTurnover46.52%IV0.03%PremiumOct 11, 2024Expiry Date1.32Intrinsic Value100Multiplier3DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.8541Delta0.1937Gamma20.84Leverage Ratio-0.0438Theta-0.0017Rho-17.80Eff Leverage0.0059Vega
Pfizer Stock Discussion
Yesterday, 51.4 million shares were traded at 29.xx. The funds and big players had bought the shares at 29.xx and they have to push it up in order to make profit. Otherwise, they are just wasting time buying the stock
The chart shows rising window today. The bands are widening. The stock is trading above 5 EMA, 10 EMA, 20 EMA and 60 EMA. The trend is likely to be up. The share price may be heading towards 30.17.
Gapping up
$Pfizer (PFE.US)$ stock increased by 3.4% following a Bloomberg report that activist investor Starboard Value acquired approximately $1 billion in shares of the pharmaceutical giant, aiming to drive a turnaround for the company.
$Hims & Hers Health (HIMS.US)$ saw its stock rise by 5.4% after it was announced that the telehealth company would be joining the S&P SmallCap 600, replacing Vector Group, the...
Overnight price gap up. Hopefully, the stock price can rocket above $30 soon with activist investor, Starboard Value seeking to mount a turnaround at Pfizer
Activist investor Starboard Value has a roughly $1 billion stake in pharmaceutical giant Pfizer and is seeking to mount a turnaround at the struggling company, according to people familiar with the matter.
The activist’s exact plans could not be learned, but Starboard has approached former Pfizer CEO Ian Read and ex-finance chief Frank D’Amelio, both of whom have expressed interest in supporting Starboard’s turnaround, said the people.
Starboard believes that Pfizer’s current le...
No comment yet